Pancreatic Cancer Research

ResearcherThe University of SydneyActive in the last 2 years

Sivakumar Gananadha

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4603-089X; OpenAlex author ID A5020583264. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 4

  1. International survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot. Co-author DOI 10.1016/j.suronc.2026.102580↗
  2. Neoadjuvant Chemotherapy With Chemoradiotherapy for Patients With Borderline Resectable or Locally Advanced Pancreatic Ductal Adenocarcinoma-Retrospective Revi… Co-author DOI 10.1111/ajco.14166↗
  3. Neoadjuvant Chemotherapy in Pancreatic Cancer. Last author DOI 10.1001/jamasurg.2020.6276↗
  4. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1245/s10434-014-3554-4↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ankit Jain · 2 shared papers, 2021–2025 · strength 0.52
  2. Desmond Yip · 2 shared papers, 2021–2025 · strength 0.52
  3. Avtaj Nerwal · 1 shared paper, 2025 · strength 0.30
  4. Belinda Lee · 1 shared paper, 2025 · strength 0.30
  5. Stephen John Clarke · 1 shared paper, 2014 · strength 0.04
  6. Jaswinder Singh Samra · 1 shared paper, 2014 · strength 0.04
  7. Frank Wang · 1 shared paper, 2014 · strength 0.04
  8. Nick Pavlakis · 1 shared paper, 2014 · strength 0.04
  9. Anthony James Gill · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.